Research Article
Clinical Characteristics and Prognosis of Gastrointestinal Metastases in Solid Tumor Patients: A Retrospective Study and Review of Literatures
Table 1
Clinical characteristics of patients with gastrointestinal metastases.
| | Metastatic gastric cancer | Metastatic colorectal cancer | All | | | % | | % | | % |
| | Age (years), median (range) | 62 (50-79) | 55 (34-73) | 56 (34-79) | | Gender | | | | Male | 2 | 22.2 | 11 | 52.4 | 13 | 43.3 | | Female | 7 | 77.8 | 10 | 47.6 | 17 | 56.7 | | Metastatic time | | | | Synchronous metastases | 4 | 44.4 | 10 | 47.6 | 14 | 46.7 | | Metachronous metastases | 5 | 55.6 | 11 | 52.4 | 16 | 53.3 | | Primary carcinoma sites | | | | Hepatic cancer | 0 | | 1 | 4.8 | 1 | 3.3 | | Gastric cancer | — | | 9 | 42.9 | 9 | 30.0 | | Breast cancer | 5 | 55.6 | 6 | 28.6 | 11 | 36.7 | | Colorectal cancer | 3 | 33.3 | — | | 3 | 10.0 | | Lung cancer | 0 | | 4 | 19.0 | 4 | 13.3 | | Esophageal cancer | 0 | | 1 | 4.8 | 1 | 3.3 | | Endometrial cancer | 1 | 11.1 | 0 | | 1 | 3.3 | | Histology | | | | | Adenocarcinoma | 4 | 44.4 | 12 | 57.1 | 16 | 53.3 | | Squamous carcinoma | 0 | | 1 | 4.8 | 1 | 3.3 | | Invasive ductal carcinoma | 4 | 44.4 | 5 | 23.8 | 9 | 30.0 | | Invasive lobular carcinoma | 1 | 11.1 | 0 | | 1 | 3.3 | | Sarcoma | 0 | | 1 | 4.8 | 1 | 3.3 | | Hepatocellular carcinoma | 0 | | 1 | 4.8 | 1 | 3.3 | | With common metastasis | | | Lymph node | 1 | 11.1 | 8 | 38.1 | 9 | 30.0 | | Lung | 2 | 22.2 | 5 | 23.8 | 7 | 23.3 | | Liver | 1 | 11.1 | 5 | 23.8 | 6 | 20.0 | | Bone | 5 | 55.6 | 10 | 47.6 | 15 | 50.0 | | Adrenal gland | 0 | | 4 | 19.0 | 4 | 13.3 | | Ovary | 0 | | 3 | 14.3 | 3 | 10.0 | | Brain | 0 | | 3 | 14.3 | 3 | 10.0 | | Peritoneum | 1 | 11.1 | 2 | 9.5 | 3 | 10.0 | | Pelvic cavity | 0 | | 3 | 14.3 | 3 | 10.0 | | With other uncommon metastases | | | | | Bone marrow | 1 | 11.1 | 2 | 9.5 | 1 | 3.3 | | Soft tissue | 1 | 11.1 | 3 | 14.3 | 4 | 13.3 | | Breast | 0 | | 1 | 4.8 | 1 | 3.3 | | Spleen | 0 | | 1 | 4.8 | 1 | 3.3 | | Treatment | | | Gastrointestinal topical therapy (metastasectomy/radiotherapy/radiofrequency ablation/microwave coagulation)+palliative chemotherapy | 0 | | 10 | 47.6 | 10 | 33.3 | | Chemotherapy alone | 7 | 77.8 | 6 | 28.6 | 13 | 43.3 | | Best supportive care only | 2 | 22.2 | 5 | 23.8 | 7 | 23.3 |
|
|
